NPI: 1295021095 · LAKELAND, FL 33805 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/21/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/21/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,773 | $1.65M |
| 2019 | 30,323 | $2.50M |
| 2020 | 30,809 | $3.51M |
| 2021 | 22,182 | $783K |
| 2022 | 11,369 | $593K |
| 2023 | 1,158 | $50K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,047 | 1,961 | $3.20M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 31,633 | 1,457 | $1.97M |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,109 | 1,115 | $1.49M |
| A4657 | Syringe, with or without needle, each | 5,371 | 1,689 | $868K |
| J1756 | Injection, iron sucrose, 1 mg | 7,872 | 1,157 | $518K |
| 85041 | 2,327 | 1,293 | $181K | |
| 85048 | 2,318 | 1,286 | $178K | |
| 83540 | 1,869 | 1,031 | $154K | |
| 83550 | 1,873 | 1,031 | $154K | |
| 82728 | 1,742 | 935 | $144K | |
| 83970 | 1,444 | 862 | $136K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 860 | 385 | $77K |
| 90674 | 23 | 17 | $7K | |
| 82108 | 67 | 36 | $4K | |
| G0008 | Administration of influenza virus vaccine | 42 | 31 | $4K |
| 90747 | 17 | 12 | $1K |